Prescriber's Letter

April 2021 Issue

Address New Questions About COVID-19 Vaccines

You’ll get more questions about COVID-19 vaccinations...

Resources

FAQ: Communicating About COVID-19 Vaccination
Chart: COVID-19 Vaccines

Monitor BP in Patients on Injectable CGRP Antagonists (Aimovig, Etc)

You’ll hear concerns about using an injectable CGRP antagonist (Aimovig, etc) for migraine prophylaxis in patients with CV risks...

Identify Candidates for COVID-19 Monoclonal Antibodies

Bamlanivimab/etesevimab will be the third monoclonal antibody option authorized to treat OUTpatients with COVID-19...

Put Inhaled and Oral COVID-19 Treatments in Perspective

You’ll hear buzz about whether to use inhaled corticosteroids, colchicine, or fluvoxamine in OUTpatients with COVID-19...

GO TO FULL ISSUE

COVID-19

Infusion pump feeds IV drip into patient's arm

Treatments of Interest for COVID-19

VTE Prevention Strategies in COVID-19

COVID Pharmacotherapy FAQs: Addressing Patient Questions

BROWSE MORE RESOURCES

New Charts

Choosing a Hormonal Contraceptive

Using Common Medications in Liver Impairment

Janus Kinase Inhibitor Adverse Effects

MORE POPULAR CHARTS

Med Updates

Verquvo
vericiguat
A guanylate cyclase stimulator for patients with symptomatic chronic heart failure and ejection fraction <45%

Cabenuva
cabotegravir/rilpivirine
A co-packaged injectable integrase strand transfer inhibitor and non-nucleoside reverse transcriptase inhibitor for HIV-1 infection

Byfavo
remimazolam
New IV benzodiazepine for procedural sedation

MORE NEW DRUGS

Acute Care

Journal Club

April
Bamlanivimab Alone or With Etesevimab to Treat Outpatients With COVID-19
March
Single Maintenance and Reliever Therapy for Persistent Asthma
February
Sacubitril/Valsartan for Heart Failure With Preserved Ejection Fraction
MORE JOURNAL CLUB TOPICS